Cell‑cell fusion as an important mechanism of tumor metastasis (Review)
- Authors:
- Xiao-Chun Peng
- Min Zhang
- Ying-Ying Meng
- Yan-Fang Liang
- Ying-Ying Wang
- Xiao-Qin Liu
- Wen-Qi Cai
- Yang Zhou
- Xian-Wang Wang
- Zhao-Wu Ma
- Ying Xiang
- Li-Si Zeng
- Shu-Zhong Cui
- Liu-Ming Yang
- Hong-Wu Xin
-
Affiliations: Department of Pathophysiology, School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, Hubei 434023, P.R. China, Teaching and Research Division of Internal Medicine, Hubei College of Chinese Medicine, Jingzhou, Hubei 434020, P.R. China, Laboratory of Oncology, Center for Molecular Medicine, School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, Hubei 434023, P.R. China, Department of Radiology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong 510095, P.R. China, State Key Laboratory of Respiratory Disease, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong 510095, P.R. China, Department of Gastroenterology and Hepatology, Affiliated Lianjiang Hospital of Guangdong Medical University and Lianjiang People's Hospital, Lianjiang, Guangdong 524400, P.R. China - Published online on: May 31, 2021 https://doi.org/10.3892/or.2021.8096
- Article Number: 145
This article is mentioned in:
Abstract
 |
 |
 |
|
Fonseca NA, Cruz AF, Moura V, Simões S and Moreira JN: The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors. Crit Rev Oncol Hematol. 113:111–121. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Xin HW, Hari DM, Mullinax JE, Ambe CW, Koizumi T, Ray S, Anderson AJ, Wiegand GW, Garfield SH, Thorgeirsson SS and Avital I: Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division. Stem Cells. 30:591–598. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Xin HW, Ambe CM, Ray S, Kim BK, Koizumi T, Wiegand GW, Hari D, Mullinax JE, Jaiswal KR, Garfield SH, et al: Wnt and the cancer niche: Paracrine interactions with gastrointestinal cancer cells undergoing asymmetric cell division. J Cancer. 4:447–457. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Xin HW, Ambe CM, Miller TC, Chen JQ, Wiegand GW, Anderson AJ, Ray S, Mullinax JE, Hari DM, Koizumi T, et al: Liver label retaining cancer cells are relatively resistant to the reported anti-cancer stem cell drug metformin. J Cancer. 7:1142–11451. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xin HW, Ambe CM, Hari DM, Wiegand GW, Miller TC, Chen JQ, Anderson AJ, Ray S, Mullinax JE, Koizumi T, et al: Label-retaining liver cancer cells are relatively resistant to sorafenib. Gut. 62:1777–1786. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hari D, Xin HW, Jaiswal K, Wiegand G, Kim BK, Ambe C, Burka D, Koizumi T, Ray S, Garfield S, et al: Isolation of live label-retaining cells and cells undergoing asymmetric cell division via nonrandom chromosomal cosegregation from human cancers. Stem Cells Dev. 20:1649–1658. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kiberstis PA: Micromanaging muscle cell fusion. Science. 356:280–281. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Liu Q, Luo K, Chen X, Xiao J, Zhang C, Tao M, Zhao R and Liu S: Cell fusion as the formation mechanism of unreduced gametes in the gynogenetic diploid hybrid fish. Sci Rep. 6:316582016. View Article : Google Scholar : PubMed/NCBI | |
|
Mohler WA, Shemer G, del Campo JJ, Valansi C, Opoku-Serebuoh E, Scranton V, Assaf N, White JG and Podbilewicz B: The type I membrane protein EFF-1 is essential for developmental cell fusion. Dev Cell. 2:355–362. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Shemer G, Suissa M, Kolotuev I, Nguyen KC, Hall DH and Podbilewicz B: EFF-1 is sufficient to initiate and execute tissue-specific cell fusion in C. elegans. Curr Biol. 14:1587–1591. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Forkner CE: The origin and fate of two types of multi-nucleated giant cells in the circulating blood. J Exp Med. 52:279–297. 1930. View Article : Google Scholar : PubMed/NCBI | |
|
Enders JF and Peebles TC: Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med. 86:277–286. 1954. View Article : Google Scholar : PubMed/NCBI | |
|
Barski G: ‘Hybrid’ cell clones isolated from mixed cell cultures. C R Hebd Seances Acad Sci. 253:1186–1188. 1961.(In French). PubMed/NCBI | |
|
Furusawa E and Cutting W: Loss of neurotropic pathogenicity and hemagglutinating property of Columbia SK virus by in vitro cultivation in sarcoma 180 ascites cells. Proc Soc Exp Biol Med. 109:417–421. 1962. View Article : Google Scholar : PubMed/NCBI | |
|
Cascardo MR and Karzon DT: Measles virus giant cell induction factor (fusion factor). Virology. 26:311–325. 1965. View Article : Google Scholar : PubMed/NCBI | |
|
Harris H and Watkins JF: Hybrid cells derived from mouse and man: Artificial heterokaryons of mammalian cells from different species. Nature. 205:640–646. 1965. View Article : Google Scholar : PubMed/NCBI | |
|
Goldenberg DM: On the progression of malignancy: A hypothesis. Klin Wochenschr. 46:898–899. 1968.(In German). View Article : Google Scholar : PubMed/NCBI | |
|
Poste G: Virus-induced polykaryocytosis and the mechanism of cell fusion. Adv Virus Res. 16:303–356. 1970. View Article : Google Scholar : PubMed/NCBI | |
|
Goldenberg DM, Pavia RA and Tsao MC: In vivo hybridisation of human tumour and normal hamster cells. Nature. 250:649–651. 1974. View Article : Google Scholar : PubMed/NCBI | |
|
Klein PA, Xiang JH and Kimura AK: Melanoma cells growing in aggregates on a non-adhesive poly(HEMA) substrate exhibit polykaryocytosis but do not develop an increased metastatic capability. Clin Exp Metastasis. 2:287–295. 1984. View Article : Google Scholar : PubMed/NCBI | |
|
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 367:645–648. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Gibson AJ, Karasinski J, Relvas J, Moss J, Sherratt TG, Strong PN and Watt DJ: Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle. J Cell Sci. 108:207–214. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Goldenberg DM, Gold DV, Loo M, Liu D, Chang CH and Jaffe ES: Horizontal transmission of malignancy: In-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology. PLoS One. 8:e553242013. View Article : Google Scholar : PubMed/NCBI | |
|
Kato K, Satouh Y, Nishimasu H, Kurabayashi A, Morita J, Fujihara Y, Oji A, Ishitani R, Ikawa M and Nureki O: Structural and functional insights into IZUMO1 recognition by JUNO in mammalian fertilization. Nat Commun. 7:121982016. View Article : Google Scholar : PubMed/NCBI | |
|
Smith JA, Hall AE and Rose MD: Membrane curvature directs the localization of Cdc42p to novel foci required for cell-cell fusion. J Cell Biol. 216:3971–3980. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Zhang Y, Li WJ, Jiang Y, Zhu Z, Hu H, Li W, Wu JW, Wang ZX, Dong MQ, et al: Spectraplakin induces positive feedback between fusogens and the actin cytoskeleton to promote cell-cell fusion. Dev Cell. 41:107–120. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Di Gioia SA, Connors S, Matsunami N, Cannavino J, Rose MF, Gilette NM, Artoni P, de Macena Sobreira NL, Chan WM, Webb BD, et al: A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome. Nat Commun. 8:160772017. View Article : Google Scholar : PubMed/NCBI | |
|
Lee JH, Hsieh CF, Liu HW, Chen CY, Wu SC, Chen TW, Hsu CS, Liao YH, Yang CY, Shyu JF, et al: Lipid raft-associated stomatin enhances cell fusion. FASEB J. 31:47–59. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Mortensen K, Lichtenberg J, Thomsen PD and Larsson LI: Spontaneous fusion between cancer cells and endothelial cells. Cell Mol Life Sci. 61:2125–2131. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Song K, Song Y, Zhao XP, Shen H, Wang M, Yan TL, Liu K and Shang ZJ: Oral cancer/endothelial cell fusion experiences nuclear fusion and acquisition of enhanced survival potential. Exp Cell Res. 328:156–163. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Raj AT, Kheur S, Patil VR and Gupta AA: Assessing the role of cell fusion in cancer metastasis. Oral Oncol. 90:124–125. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Song K, Zhu F, Zhang Hz and Shang Zj: Tumor necrosis factor-α enhanced fusions between oral squamous cell carcinoma cells andendothelial cells via VCAM-1/VLA-4 pathway. Exp Cell Res. 318:1707–1715. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rappa G, Mercapide J and Lorico A: Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. Am J Pathol. 180:2504–2515. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang R, Chen S, Li C, Ng KTP, Kong Cw, Cheng J, Cheng SH, Li RA, Lo CM, Man K and Sun D: Fusion with stem cell makes the hepatocellular carcinoma cells similar to liver tumor--initiating cells. BMC Cancer. 16:562016. View Article : Google Scholar : PubMed/NCBI | |
|
Noubissi FK, Harkness T, Alexander CM and Ogle BM: Apoptosis-induced cancer cell fusion: A mechanism of breast cancer metastasis. FASEB J. 29:4036–4045. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Melzer C, von der Ohe J and Hass R: Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma/stem cells (MSC). Cell Commun Signal. 16:22018. View Article : Google Scholar : PubMed/NCBI | |
|
Melzer C, von der Ohe J and Hass R: Involvement of actin cytoskeletal components in breast cancer cell fusion with human mesenchymal stroma/stem-like cells. Int J Mol Sci. 20:8762019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu MH, Gao X, Luo D, Zhou XD, Xiong W and Liu GX: EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells. PLoS One. 9:e878932014. View Article : Google Scholar : PubMed/NCBI | |
|
Xue J, Zhu Y, Sun Z, Ji R, Zhang X, Xu W, Yuan X, Zhang B, Yan Y, Yin L, et al: Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness. BMC Cancer. 15:7932015. View Article : Google Scholar : PubMed/NCBI | |
|
Sun C, Zhao D, Dai X, Chen J, Rong X, Wang H, Wang A, Li M, Dong J, Huang Q and Lan Q: Fusion of cancer stem cells and mesenchymal stem cells contributes to glioma neovascularization. Oncol Rep. 34:2022–2030. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang LN, Kong CF, Zhao D, Cong XL, Wang SS, Ma L and Huang YH: Fusion with mesenchymal stem cells differentially affects tumorigenic and metastatic abilities of lung cancer cells. J Cell Physiol. 234:3570–3582. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Feng Z, Tsang TC, Tang T, Jia X, He X, Pennington ME, Badowski MS, Liu AKM, Chen D, et al: Fusion of HepG2 cells with mesenchymal stem cells increases cancer associated and malignant properties: An in vivo metastasis model. Oncol Rep. 32:539–547. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yin L, Hu P, Shi X, Qian W, Zhau HE, Pandol SJ, Lewis MS, Chung LWK and Wang R: Cancer cell's neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction. Sci Rep. 10:12162020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Yang L, Wang D, Zhang Q and Zhang L: Pro-tumor activities of macrohpages in the progression of melanoma. Hum Vaccin Immunother. 13:1556–1562. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang LN, Huang YH and Zhao L: Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway. Arch Biochem Biophys. 676:1081372019. View Article : Google Scholar : PubMed/NCBI | |
|
Ding J, Jin W, Chen C, Shao Z and Wu J: Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PLoS One. 7:e419422012. View Article : Google Scholar : PubMed/NCBI | |
|
Chakraborty AK, Pawelek J, Ikeda Y, Miyoshi E, Kolesnikova N, Funasaka Y, Ichihashi M and Taniguchi N: Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyltransferase V, beta1-6 branching, and metastasis. Cell Growth Differ. 12:623–630. 2001.PubMed/NCBI | |
|
Kemény LV, Kurgyis Z, Buknicz T, Groma G, Jakab A, Zänker K, Dittmar T, Kemény L and Németh IB: Melanoma cells can adopt the phenotype of stromal fibroblasts and macrophages by spontaneous cell fusion in vitro. Int J Mol Sci. 17:8262016. View Article : Google Scholar | |
|
Kurgyis Z, Kemény LV, Buknicz T, Groma G, Oláh J, Jakab A, Polyánka H, Zänker K, Dittmar T, Kemény L and Németh IB: Melanoma-Derived BRAF (V600E) mutation in peritumoral stromal cells: Implications for in vivo cell fusion. Int J Mol Sci. 17:9802016. View Article : Google Scholar : PubMed/NCBI | |
|
Lindström A, Midtbö K, Arnesson LG, Garvin S and Shabo I: Fusion between M2-macrophages and cancer cells results in a subpopulation of radioresistant cells with enhanced DNA-repair capacity. Oncotarget. 8:51370–51386. 2017. View Article : Google Scholar | |
|
He K, Qu H, Xu LN, Gao J, Cheng FY, Xiang P and Zhou CQ: Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells. Biosci Rep. 36:e003782016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Fan H, Zhou B, Ju Z, Yu L, Guo L, Han J and Lu S: Fusion of human umbilical cord mesenchymal stem cells with esophageal carcinoma cells inhibits the tumorigenicity of esophageal carcinoma cells. Int J Oncol. 40:370–377. 2012.PubMed/NCBI | |
|
Fan H and Lu S: Fusion of human bone hemopoietic stem cell with esophageal carcinoma cells didn't generate esophageal cancer stem cell. Neoplasma. 61:540–545. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kim TB, Park HK, Chang JH, Choi IH, Kim KH, Yoon SJ, Lee MS, Jung H and Kim CS: The establishment of dendritic cell-tumor fusion vaccines for hormone refractory prostate cancer cell. Korean J Urol. 51:139–144. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yoo C, Do HA, Jeong IG, Park H, Hwang JJ, Hong JH, Cho JS, Choo MS, Ahn H and Kim CS: Efficacy of dendritic cells matured early with OK-432 (Picibanil), prostaglandin E2, and interferon-alpha as a vaccine for a hormone refractory prostate cancer cell line. J Korean Med Sci. 25:1284–1290. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kawada M, Ikeda H, Takahashi T, AIshizu A, Ishikura H, Katoh H and Yoshiki T: Vaccination of fusion cells of rat dendritic and carcinoma cells prevents tumor growth in vivo. Int J Cancer. 105:520–526. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Matsumoto S, Saito H, Tsujitani S and Ikeguchi M: Allogeneic gastric cancer cell-dendritic cell hybrids induce tumor antigen (carcinoembryonic antigen) specific CD8(+) T cells. Cancer Immunol Immunother. 55:131–139. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, et al: Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells. Clin Cancer Res. 11:7891–7900. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang K, Gao PF, Yu PW, Rao Y and Zhou LX: Study on biological characters of SGC7901 gastric cancer cell-dendritic cell fusion vaccines. World J Gastroenterol. 12:3438–3441. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Imura K, Ueda Y, Hayashi T, Itoh T, Shimizu K, Tamai H, Yano Y, Naito K, Kohara J, Nakane K, et al: Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique. Int J Oncol. 29:531–539. 2006.PubMed/NCBI | |
|
Zhang Y, Ma B, Zhou Y, Zhang M, Qiu X, Sui Y, Zhang X, Ma B and Fan Q: Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells. Breast Cancer Res Treat. 105:277–286. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Koido S, Tanaka Y, Tajiri H and Gong J: Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells. Vaccine. 25:2610–2619. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Serhal K, Baillou C, Ghinea N, Fontanges P, Dupuy FP, Lemoine FM and Lacave R: Characteristics of hybrid cells obtained by dendritic cell/tumour cell fusion in a T-47D breast cancer cell line model indicate their potential as anti-tumour vaccines. Int J Oncol. 31:1357–1365. 2007.PubMed/NCBI | |
|
Hu Z, Chen J, Zhou S, Yang N, Duan S, Zhang Z, Su J, He J, Zhang Z, Lu X and Zhao Y: Mouse IP-10 gene delivered by folate-modified chitosan nanoparticles and dendritic/tumor cells fusion vaccine effectively inhibit the growth of hepatocellular carcinoma in mice. Theranostics. 7:1942–1952. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Dittmar T, Schwitalla S, Seidel J, Haverkampf S, Reith G, Meyer-Staeckling S, Brandt BH, Niggemann B and Zänker KS: Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Clin Exp Metastasis. 28:75–90. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ozel C, Seidel J, Meyer-Staeckling S, Brandt BH, Niggemann B, Zänker KS and Dittmar T: Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk. Cell Commun Signal. 10:102012. View Article : Google Scholar : PubMed/NCBI | |
|
Gauck D, Keil S, Niggemann B, Zänker KS and Dittmar T: Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells. BMC Cancer. 17:5152017. View Article : Google Scholar : PubMed/NCBI | |
|
Bhatia B, Multani AS, Patrawala L, Chen X, Calhoun-Davis T, Zhou J, Schroeder L, Schneider-Broussard R, Shen J, Pathak S, et al: Evidence that senescent human prostate epithelial cells enhance tumorigenicity: Cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT. Int J Cancer. 122:1483–1495. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kerbel RS, Lagarde AE, Dennis JW and Donaghue TP: Spontaneous fusion in vivo between normal host and tumor cells: Possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol Cell Biol. 3:523–538. 1983. View Article : Google Scholar : PubMed/NCBI | |
|
Chakraborty AK, Sodi S, Rachkovsky M, Kolesnikova N, Platt JT, Bolognia JL and Pawelek JM: A spontaneous murine melanoma lung metastasis comprised of host × tumor hybrids. Cancer Res. 60:2512–2519. 2000.PubMed/NCBI | |
|
Luo F, Liu T, Wang J, Li J, Ma P, Ding H, Feng G, Lin D, Xu Y and Yang K: Bone marrow mesenchymal stem cells participate in prostate carcinogenesis and promote growth of prostate cancer by cell fusion in vivo. Oncotarget. 7:30924–30934. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sun C, Dai X, Zhao D, Wang H, Rong X, Huang Q and Lan Q: Mesenchymal stem cells promote glioma neovascularization in vivo by fusing with cancer stem cells. BMC Cancer. 19:12402019. View Article : Google Scholar : PubMed/NCBI | |
|
Jacobsen BM, Harrell JC, Jedlicka P, Borges VF, Varella-Garcia M and Horwitz KB: Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium. Cancer Res. 66:8274–8279. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Martin-Padura I, Marighetti P, Gregato G, Agliano A, Malazzi O, Mancuso P, Pruneri G, Viale A and Bertolini F: Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential. Neoplasia. 14:1057–1066. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chitwood CA, Dietzsch C, Jacobs G, McArdle T, Freeman BT, Banga A, Noubissi FK and Ogle BM: Breast tumor cell hybrids form spontaneously in vivo and contribute to breast tumor metastases. APL Bioeng. 2:0319072018. View Article : Google Scholar : PubMed/NCBI | |
|
Pawelek JM and Chakraborty AK: The cancer cell-leukocyte fusion theory of metastasis. Adv Cancer Res. 101:397–444. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Harkness T, Weaver BA, Alexander CM and Ogle BM: Cell fusion in tumor development: Accelerated genetic evolution. Crit Rev Oncog. 18:19–42. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chakraborty A, Lazova R, Davies S, Bäckvall H, Ponten F, Brash D and Pawelek J: Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant. 34:183–186. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yilmaz Y, Lazova R, Qumsiyeh M, Cooper D, Pawelek J and Donor Y: Chromosome in renal carcinoma cells of a female BMT recipient: Visualization of putative BMT-tumor hybrids by FISH. Bone Marrow Transplant. 35:1021–1024. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lazova R, Laberge GS, Duvall E, Spoelstra N, Klump V, Sznol M, Cooper D, Spritz RA, Chang JT and Pawelek JM: A melanoma brain metastasis with a donor-patient hybrid genome following bone marrow transplantation: First evidence for fusion in human cancer. PLoS One. 8:e667312013. View Article : Google Scholar : PubMed/NCBI | |
|
LaBerge GS, Duvall E, Grasmick Z, Haedicke K and Pawelek J: A melanoma lymphnode metastasis with a donor-patient hybrid genome following bone marrow transplantation: A second case of leucocyte-tumor cell hybridization in cancer metastasis. PLoS One. 12:e01685812017. View Article : Google Scholar : PubMed/NCBI | |
|
Andersen TL, Boissy P, Sondergaard TE, Kupisiewicz K, Plesner T, Rasmussen T, Haaber J, Kølvraa S and Delaissé JM: Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: A new type of cancer-host partnership? J Pathol. 211:10–17. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Clawson GA, Matters GL, Xin P, Imamura-Kawasawa Y, Du Z, Thiboutot DM, Helm KF, Neves RI and Abraham T: Macrophage-tumor cell fusions from peripheral blood of melanoma patients. PLoS One. 10:e01343202015. View Article : Google Scholar : PubMed/NCBI | |
|
Melzer C, von der Ohe J and Hass R: In vivo cell fusion between mesenchymal stroma/stem-like cells and breast cancer cells. Cancers (Basel). 110:1852019. View Article : Google Scholar | |
|
Hong S, Zhang P, Zhang H, Jia L, Qu X, Yang Q, Rong F and Kong B: Enforced effect of tk-MCP-1 fusion gene in ovarian cancer. J Exp Clin Cancer Res. 31:742012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang D, Li B, Shi J, Zhao L, Zhang X, Wang C, Hou S, Qian W, Kou G, Wang H and Guo Y: Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein. Cancer Res. 70:2495–2503. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Tammela T, Zarkada G, Nurmi H, Jakobsson L, Heinolainen K, Tvorogov D, Zheng W, FrancoC A, Murtomäki A, Aranda E, et al: VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol. 13:1202–1213. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Liang AL, Qian HL, Zhang TT, Zhou N, Wang HJ, Men XT, Qi W, Zhang PP, Fu M, Liang X, et al: Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer. Drug Des Devel Ther. 9:5671–5686. 2015.PubMed/NCBI | |
|
Beha N, Harder M, Ring S, Kontermann RE and Müller D: IL15-based trifunctional antibody-fusion proteins with costimulatory TNF-superfamily ligands in the single-chain format for cancer immunotherapy. Mol Cancer Ther. 18:1278–1288. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Weiler J and Dittmar T: Minocycline impairs TNF-α-induced cell fusion of M13SV1-Cre cells with MDA-MB-435-pFDR1 cells by suppressing NF-κB transcriptional activity and its induction of target-gene expression of fusion-relevant factors. Cell Commun Signal. 17:712019. View Article : Google Scholar : PubMed/NCBI | |
|
Goldenberg DM, Zagzag D, Heselmeyer-Haddad KM, Garcia LYB, Ried T, Loo M, Chang CH and Gold DV: Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo. Int J Cancer. 131:49–58. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lee SH, Lee YP, Kim SY, Jeong MS, Lee MJ, Kang HW, Jeong HJ, Kim DW, Sohn EJ, Jang SH, et al: Inhibition of LPS-induced cyclooxygenase 2 and nitric oxide production by transduced PEP-1-PTEN fusion protein in raw 264.7 macrophage cells. Exp Mol Med. 40:629–638. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Wolf S, Haase-Kohn C, Lenk J, Hoppmann S, Bergmann R, Steinbach J and Pietzsch J: Expression, purification and fluorine-18 radiolabeling of recombinant S100A4: A potential probe for molecular imaging of receptor for advanced glycation endproducts in vivo? Amino Acids. 41:809–820. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Liu XQ, Xin HY, Lyu YN, Ma ZW, Peng XC, Xiang Y, Wang YY, Wu ZJ, Cheng JT, Ji JF, et al: Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins. Drug Deliv. 25:1950–1962. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Foo CH, Rootes CL, Cowley K, Marsh GA, Gould CM, Deffrasnes C, Cowled CJ, Klein R, Riddell SJ and Middleton D: Dual microRNA screens reveal that the immune-responsive miR-181 promotes henipavirus entry and cell-cell fusion. PLoS Pathog. 12:e10059742016. View Article : Google Scholar : PubMed/NCBI | |
|
Hu C, He Y, Liu D, Zhao L, Fang S, Tan B, Dong S, Wang Y, He T and Bi Y: Hypoxia preconditioning promotes the proliferation and migration of urine-derived stem cells in chronically injured liver of mice by upregulating CXCR4. Stem Cells Dev. 15:526–536. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Luo Y, Zhu D, Lam DH, Huang J, Tang Y, Luo X and Wang S: A double-switch cell fusion-inducible transgene expression system for neural stem cell-based antiglioma gene therapy. Stem Cells Int. 2015:6490802015. View Article : Google Scholar : PubMed/NCBI |
